Progress in mesenchymal stem cells for treatment of atherosclerosis

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 29, Issue 11, 2013, Pages 1538-1547

  Liu, Jiajia ^a   Zhang, Yiting ^a   Peng, Hang ^a   Liu, Pengxia ^a  

^a INNER MONGOLIA UNIVERSITY   (China)

Author keywords

Atherosclerosis; Endothelial cells; Mesenchymal stem cells; Smooth muscle cells

Indexed keywords

ANIMAL; ATHEROSCLEROSIS; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; ENDOTHELIUM CELL; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PROCEDURES;

ANIMALS; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS;

EID: 84891882353     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Celermajer D S, Adams M R, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med, 1996, 334(3): 150-154.
2. Cardillo C, Campia U, Kilcoyne C M, et al. Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Circulation, 2002, 105(4): 452-456.
3. Casino P R, Kilcoyne C M, Quyyumi A A, et al. Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor. Am J Cardiol, 1995, 75(1): 40-44.
4. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med, 1999, 340(2): 115-126.
5. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993, 362(6423): 801-809.
6. Salem H K, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells, 2010, 28(3): 585-596.
7. Pittenger M F, Mackay A M, Beck S C, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284(5411): 143-147.
8. Reyes M, Lund T, Lenvik T, et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood, 2001, 98(9): 2615-2625.
9. Nauta A J, Fibbe W E. Immunomodulatory properties of mesenehynlal stromal cells. Blood, 2007, 110(10): 3499-3506.
10. Oswald J, Boxberger S, Jorgensen B, et al. Mesenchymal stem cell can be differentiated into endothelial cells in vitro. Stem Cells, 2004, 22(3): 377-384.
11. Forte A, Finicelli M, Mattia M, et al. Mesenchymal stem cells effectively reduce surgically induced stenosis in rat carotids. J Cell Physiol, 2008, 217(3): 789-799.
12. Chen X C, Shan H W, Qu H L. Bone marrow mesenchymal stem cell transplantation aggravates postangioplasty aortic restenosis in rats. Chin J Cardiol, 2007, 35(9): 802-806 (in Chinese).
13. Friedenstein A J, Piatetzky-Shapiro I I, Petrakova K V. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol, 1966, 16(3): 381-390.
14. Erices A, Conget P, Minguell J J. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol, 2000, 109(1): 235-242.
15. Campagnoli C, Roberts I A, Kumar S, et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood, 2001, 98(8): 2396-2402.
16. De Ugarte D A, Morizono K, Elbarbary A, et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs, 2003, 174(3): 101-109.
17. Wang H S, Hung S C, Peng S T, et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells, 2004, 22(7): 1330-1337.
18. In't Anker P S, Scherjon S A, Kleijburgvan der Keur C, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells, 2004, 22(7): 1338-1345.
19. Im G I, Shin Y W, Lee K B. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage, 2005, 13(10): 845-853.
20. Liu M, Han Z C. Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy. J Cell Mol Med, 2008, 12(4): 1155-1168.
21. Abedin M, Tintut Y, Demer L L. Mesenchymal stem cells and the artery wall. Circ Res, 2004, 95(7): 671-676.
22. Nicola M D, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 2002, 99(10): 3838-3843.
23. Djouad F, Charbonnier L M, Bouffi C, et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells, 2007, 25(8): 2025-2032.
24. Spaggiari G M, Capobianco A, Abdelrazik H, et al. Mesenchymal stem cells inhibit natural killer cell proliferation, cytotoxicity and cytokine production: role of indoleamine 2, 3-dioxygenase and prostaglandin E2. Blood, 2008, 111(3): 1327-1333.
25. Asari S, Itakura S, Ferreri K, et al. Mesenchymal stem cells suppress B cell terminal differentiation. Exp Hematol, 2009, 37(5): 604-615.
26. Schu S, Nosov M, O'Flynn L, et al. Immunogenicity of allogeneic mesenchymal stem cells. J Cell Mol Med, 2012, 16(9): 2094-2103.
27. Shi T X, Zhang M G, Ji M F, et al. Influence of erythropoietin on the induction and differentiation of human bone marrow mesenchymal stem cells into endothelial cells. Chin J Vasc Surg, 2010, 2(2): 112-116 (in Chinese).
28. Wu X J, Huang L, Zhou Q, et al. Plasticity of bone marrow stromal stem cells along endothelial lineage under different culture condition. Chin J Arterioscler, 2005, 13(4): 393-396 (in Chinese).
29. Yue W M, Liu W, Bi Y W, et al. Mesenchymal stem cells differentiate into an endothelial phenotype, reduce neointimal formation and enhance endothelial function in a rat vein grafting model. Stem Cells Dev, 2008, 17(4): 785-793.
30. Guo Y, Shi B, Wang Z L, et al. Effects of peripheral blood mesenchyme stem cells transplantation on vascular smooth muscle cell apoptosis after balloon-induced artery injury in rabbits. Chin J Biomed Eng, 2010, 29(2): 288-294 (in Chinese).
31. Liu Z J, Shi B, Xu G X. Effect of bone marrow mesenchymal stem cells transplantation on repairment of injured vascular endothelial. Chin J Arterioscler, 2011, 19(9): 716-720 (in Chinese).
32. Eirin A, Zhu XY, Krier J D, et al. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells, 2012, 30(5): 1030-1041.
33. Wang Z X, Mao S, Li Y. Effects of MSCs on the progression of atherosclerosis plaque in ApoE-knock out mice. Chin J Cell Mol Immunol, 2012, 28(3): 244-246 (in Chinese).
34. Wang C H, Cherng W J, Yang N I, et al. Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler Thromb Vasc Biol, 2008, 28(1): 54-60.
35. Peled A, Zipori D, Abramsky O, et al. Expression of alpha-smooth muscle actin in murine bone marrow stromal cells. Blood, 1991, 78(2): 304-309.
36. Charbord P, Lerat H, Newton I, et al. The cytoskeleton of stromal cells from human bone marrow cultures resembles that of cultured smooth muscle cells. Exp Hematol, 1990, 18(4): 276-282.
37. Kinner B, Zaleskas J M. Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Exp Cell Res, 2002, 278(1): 72-83.
38. Gong Z, Niklason L E. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J, 2008, 22(6): 1635-1648.
39. Yan P k, Duan C W, Li S H, et al. Effect of oxidative low-density lipoprotein on the proliferation of bone marrow stem cell-derived smooth muscle cells. J South Med Univ, 2010, 30(5): 989-992 (in Chinese).
40. Liu P X, Zhang L, Liao W B. Transfusion of allogeneic mesenchymal stem cells promotes progression of atherosclerotic plaque in rabbits. J Exp Hematol, 2009, 17(3): 700-705 (in Chinese).
41. O'Shea C A, Hynes S O, Shaw G, et al. Bolus delivery of mesenchymal stem cells to injured vasculature in the rabbit carotid artery produces a dysfunctional endothelium. Tissue Eng Part A, 2010, 16(5): 1657-1665.
42. Psaltis P J, Zannettino A C, Worthley S G, et al. Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells, 2008, 26(9): 2201-2210.
43. Satija N K, Singh V K, Verma Y K, et al. Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med, 2009, 13(11/12): 4385-4402.
44. Karp J M, Leng Teo G S. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell, 2009, 4(3): 206-216.
45. Gnecchi M, Zhang Z, Ni A, et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res, 2008, 103(11): 1204-1219.
46. Mimeault M, Hauke R, Batra S K, et al. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther, 2007, 82(3): 252-264.
47. Lozito, Kuo C K, Taboas J M, et al. Human mesenchymal stem cells express vaseular cell phenotypes upon interaction with endothelial cell matrix. J Cell Bioehem, 2009, 107(4): 714-722.
48. Tremain N, Korkko J, Ibberson D, et al. MicroSAGE analysis of 2353 expressed genes in a single c ell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages. Stem Cells, 2001, 19(5): 408-418.
49. Yuan W D, Sun X H, Fang X U. Study on differentiation of bone marrow mesenchymal stem cells in coculture with the adventitial fibroblasts cells. Life Sci Res, 2012, 16(5): 441-445 (in Chinese).
50. Goerke S M, Plaha J, Hager S, et al. Human endothelial progenitor cells induce extracellular signal-regulated kinase-dependent differentiation of mesenchymal stem cells into smooth muscle cells upon cocultivation. Tissue Eng Part A, 2012, 18(23-24): 2395-2405.
51. Janmaat M L, Heerkens J L, de Bruin A M, et al. Erythropoietin accel-erates smooth muscle cell-rich vascular lesion formation in mice through endothelial cell activation involving enhanced PDGF-BB release. Blood, 2010, 115(7): 1453-1460.
52. Ball S G, Shuttleworth C A, Kielty C M. Platelet- derived growth factor receptor-alpha is a key determinant of smooth muscle alpha-actin filaments in bone marrow-derived mesenchymal stem cells. Int J Biochem Cell Biol, 2007, 39(2): 379-391.